Beneficencia Portuguesa de Sao Paulo

São Paulo, São Paulo 01323-900

0 studies enrolling now · 4 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer, KRAS p, G12c Mutated /Advanced Metastatic NSCLC, Sickle Cell Disease, Urothelial Carcinoma

Studies at this site

• Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). — Completed
• A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer) — Running, not enrolling
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD) — Completed
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed